Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-β k.o. and wild type mice

A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2^b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells

Itzhack Mendel, Nicole Kerlero de Rosbo, Avraham Ben‐Nun · European Journal of Immunology · 1995 · 604 citations

Life Sciences, Neurology, Neuroscience +17

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

David A. Katz, Jeffery K. Taubenberger, Barbara Cannella et al. · Annals of Neurology · 1993 · 387 citations

Medicine, Neurology, Radiology +17

Blood–brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis

Sarah Floris, Erwin L. A. Blezer, Gerty Schreibelt et al. · Brain · 2004 · 266 citations

Life Sciences, Neurology, Neuroscience +17

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS

Chris H. Polman, Frederik Barkhof, Magnhild Sandberg‐Wollheim et al. · Neurology · 2005 · 228 citations

Pharmacy, Neurology, Pharmacotherapy +14

DURATION AND SELECTIVITY OF BLOOD-BRAIN BARRIER BREAKDOWN IN CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS STUDIED BY GADOLINIUM-DTPA AND PROTEIN MARKERS

Philip N. Hawkins, Peter Munro, F.J. MacKenzie et al. · Brain · 1990 · 220 citations

Life Sciences, Neurology, Neuroscience +16